How do participants feel about analytical treatment interruptions in HIV cure-directed trials?
Gene editing may not be the safest HIV cure strategy, early findings warn
Nearly 13% of participants in an African cohort maintain HIV control off treatment
CRISPR gene therapy appears safe, but claims of an imminent HIV cure are premature
PD-1 inhibitor budigalimab may delay viral rebound
Man controls HIV for 23 years after a short course of treatment
Defective HIV particles may drive inflammation despite long-term viral suppression
Another class of cancer drugs may contribute to curing HIV
Antibodies that ‘wait and pounce’ generated by promising HIV vaccine candidate
